Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Palmitoylacyltransferase Zdhhc9 inactivation mitigates leukemogenic potential of oncogenic Nras.

Literature DB >> 26493479

Palmitoylacyltransferase Zdhhc9 inactivation mitigates leukemogenic potential of oncogenic Nras.

P Liu¹, B Jiao¹, R Zhang¹, H Zhao¹, C Zhang¹, M Wu¹, D Li¹, X Zhao¹, Q Qiu¹, J Li¹, R Ren^1,2.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2015 PMID： 26493479 DOI： 10.1038/leu.2015.293

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

× No keyword cloud information.

15 in total

Review 1. DHHC palmitoyl transferases: substrate interactions and (patho)physiology.

Authors: Jennifer Greaves; Luke H Chamberlain
Journal: Trends Biochem Sci Date: 2011-03-08 Impact factor: 13.807

2. Palmitoylation of oncogenic NRAS is essential for leukemogenesis.

Authors: Benjamin Cuiffo; Ruibao Ren
Journal: Blood Date: 2010-03-03 Impact factor: 22.113

3. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.

Authors: Clara Ricci; Elisa Fermo; Stefania Corti; Mauro Molteni; Alessio Faricciotti; Agostino Cortelezzi; Giorgio Lambertenghi Deliliers; Miloslav Beran; Francesco Onida
Journal: Clin Cancer Res Date: 2010-04-06 Impact factor: 12.531

Review 4. Targeting oncogenic Ras signaling in hematologic malignancies.

Authors: Ashley F Ward; Benjamin S Braun; Kevin M Shannon
Journal: Blood Date: 2012-08-16 Impact factor: 22.113

5. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Authors: Jinghui Zhang; Li Ding; Linda Holmfeldt; Gang Wu; Sue L Heatley; Debbie Payne-Turner; John Easton; Xiang Chen; Jianmin Wang; Michael Rusch; Charles Lu; Shann-Ching Chen; Lei Wei; J Racquel Collins-Underwood; Jing Ma; Kathryn G Roberts; Stanley B Pounds; Anatoly Ulyanov; Jared Becksfort; Pankaj Gupta; Robert Huether; Richard W Kriwacki; Matthew Parker; Daniel J McGoldrick; David Zhao; Daniel Alford; Stephen Espy; Kiran Chand Bobba; Guangchun Song; Deqing Pei; Cheng Cheng; Stefan Roberts; Michael I Barbato; Dario Campana; Elaine Coustan-Smith; Sheila A Shurtleff; Susana C Raimondi; Maria Kleppe; Jan Cools; Kristin A Shimano; Michelle L Hermiston; Sergei Doulatov; Kolja Eppert; Elisa Laurenti; Faiyaz Notta; John E Dick; Giuseppe Basso; Stephen P Hunger; Mignon L Loh; Meenakshi Devidas; Brent Wood; Stuart Winter; Kimberley P Dunsmore; Robert S Fulton; Lucinda L Fulton; Xin Hong; Christopher C Harris; David J Dooling; Kerri Ochoa; Kimberly J Johnson; John C Obenauer; William E Evans; Ching-Hon Pui; Clayton W Naeve; Timothy J Ley; Elaine R Mardis; Richard K Wilson; James R Downing; Charles G Mullighan
Journal: Nature Date: 2012-01-11 Impact factor: 49.962

6. Leukemic marrow infiltration reveals a novel role for Egr3 as a potent inhibitor of normal hematopoietic stem cell proliferation.

Authors: Hui Cheng; Sha Hao; Yanfeng Liu; Yakun Pang; Shihui Ma; Fang Dong; Jing Xu; Guoguang Zheng; Shaoguang Li; Weiping Yuan; Tao Cheng
Journal: Blood Date: 2015-07-17 Impact factor: 22.113

7. Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner.

Authors: Jinyong Wang; Yangang Liu; Zeyang Li; Zhongde Wang; Li Xuan Tan; Myung-Jeom Ryu; Benjamin Meline; Juan Du; Ken H Young; Erik Ranheim; Qiang Chang; Jing Zhang
Journal: Blood Date: 2011-05-17 Impact factor: 22.113

Review 8. Protein lipidation.

Authors: Marissa J Nadolski; Maurine E Linder
Journal: FEBS J Date: 2007-09-24 Impact factor: 5.542

9. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon.

Authors: Kevin M Haigis; Krystle R Kendall; Yufang Wang; Ann Cheung; Marcia C Haigis; Jonathan N Glickman; Michiko Niwa-Kawakita; Alejandro Sweet-Cordero; Judith Sebolt-Leopold; Kevin M Shannon; Jeffrey Settleman; Marco Giovannini; Tyler Jacks
Journal: Nat Genet Date: 2008-03-30 Impact factor: 38.330

10. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia.

Authors: Elisabetta Flex; Valentina Petrangeli; Lorenzo Stella; Sabina Chiaretti; Tekla Hornakova; Laurent Knoops; Cristina Ariola; Valentina Fodale; Emmanuelle Clappier; Francesca Paoloni; Simone Martinelli; Alessandra Fragale; Massimo Sanchez; Simona Tavolaro; Monica Messina; Giovanni Cazzaniga; Andrea Camera; Giovanni Pizzolo; Assunta Tornesello; Marco Vignetti; Angela Battistini; Hélène Cavé; Bruce D Gelb; Jean-Christophe Renauld; Andrea Biondi; Stefan N Constantinescu; Robin Foà; Marco Tartaglia
Journal: J Exp Med Date: 2008-03-24 Impact factor: 14.307

21 in total

Review 1. Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive Ras.

Authors: Anica Wandler; Kevin Shannon
Journal: Cold Spring Harb Perspect Med Date: 2018-04-02 Impact factor: 6.915

Review 2. Posttranslational Modifications of RAS Proteins.

Authors: Ian Ahearn; Mo Zhou; Mark R Philips
Journal: Cold Spring Harb Perspect Med Date: 2018-11-01 Impact factor: 6.915

3. Palmitoylation stabilizes PD-L1 to promote breast tumor growth.

Authors: Yi Yang; Jung-Mao Hsu; Linlin Sun; Li-Chuan Chan; Chia-Wei Li; Jennifer L Hsu; Yongkun Wei; Weiya Xia; Junwei Hou; Yufan Qiu; Mien-Chie Hung
Journal: Cell Res Date: 2018-12-04 Impact factor: 25.617

Review 4. Protein palmitoylation and cancer.

Authors: Pin-Joe Ko; Scott J Dixon
Journal: EMBO Rep Date: 2018-09-19 Impact factor: 8.807